Shanghai Fudan Forward S&T (600624) Stock Overview

Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supplies and lead-acid batteries, as well as professional agent of car audio brand. In addition, the company provides corporate investment and consulting, and venture capital investment solutions. Further, it engages in the research and development, production, and sales of computer systems, communication equipment, automation instruments, biotechnology, light source lightings, and other products. Shanghai Fudan Forward S&T Co., Ltd was founded in 1984 and is based in Shanghai, China.